Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Medtronic, Inc. (NYSE:MDT)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Reports
Recent Events
Aug 20Earnings Announcement
Aug 20Conference call: Medtronic Earnings (Q1 2002)
Upcoming Events
Oct 26Dividend payment of $0.058
Location
710 Medtronic Parkway N.E.
Minneapolis, MN 55432
Phone: (763) 514-4000
Fax: (763) 514-6272
Email: webmaster@medtronic.com
Employees (last reported count): 26,050
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Subsidiaries
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 500
Ownership
·Insider and 5%+ Owners: 1%
·Over the last 6 months:
 · 6 insider sells; 72.0K shares
  (0.6% of insider shares)
·Institutional: 66% (66% of float)
(2,012 institutions)
·Net Inst. Buying: 8.92M shares (+1.11%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Medtronic, Inc. is a medical technology company that provides lifelong solutions for people with chronic disease. The Company offers therapies to restore patients worldwide to fuller, healthier lives. Medtronic's primary products are used for bradycardia pacing, tachyarrhythmia management, atrial fibrillation, heart failure, coronary and peripheral vascular disease, minimally invasive cardiac surgery, heart valve replacement, extracorporeal cardiac support, spinal and neurosurgery, malignant and non-malignant pain, movement disorders, neurodegenerative disorders, and ear, nose and throat (ENT) surgery. Medtronic conducts business through four units: Cardiac Rhythm Management; Vascular; Cardiac Surgery; and Neurological, Spinal and ENT.
More from Market Guide: Expanded Business Description

Financial Summary
Medtronic, Inc. is a medical technology company engaged in manufacturing and selling device-based medical therapies. The Company's product lines include cardiac rhythm management, neurological, and spinal, vascular and cardiac surgery. For the fiscal year ended 4/27/01, net sales rose 11% to $5.55 billion. Net income fell 4% to $1.05 billion. Revenues reflect increased sales of neurological and vascular products. Net income reflects higher non-recurring charges.

Recent Earnings Announcement
For the 3 months ended 07/27/2001, revenues were 1,455,700; after tax earnings were 301,500. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

William George, 57
Chairman
$1.6M$6.4M
Arthur Collins, Jr., 52
Pres, CEO, Director
1.5M4.0M
Glen Nelson, M.D., 63
Vice Chairman
681K5.6M
Robert Ryan, 57
Sr. VP and CFO
448K2.6M
David Scott, 47
Sr. VP and Gen. Counsel
--  --  
Dollar amounts are as of 30-Apr-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:MDTAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$39.95 
Recent Price$45.54 
52-Week High
on 28-Dec-2000
$62.00 
Beta0.65 
Daily Volume (3-month avg)3.41M
Daily Volume (10-day avg)3.37M
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-12.3%
52-Week Change
relative to S&P500
+17.6%
Share-Related Items
Market Capitalization$55.1B
Shares Outstanding1.21B
Float1.20B
Dividends & Splits
Annual Dividend (indicated)$0.23 
Dividend Yield0.51%
Last Split: 2 for 1 on 27-Sep-1999
Per-Share Data
Book Value (mrq*)$4.55 
Earnings (ttm)$0.87 
Earnings (mrq)$0.25 
Sales (ttm)$4.67 
Cash (mrq*)$1.02 
Valuation Ratios
Price/Book (mrq*)10.00 
Price/Earnings (ttm)52.53 
Price/Sales (ttm)9.76 
Income Statements
Sales (ttm)$5.70B
EBITDA (ttm*)$1.85B
Income available to common (ttm)$1.06B
Profitability
Profit Margin (ttm)18.6%
Operating Margin (ttm)27.9%
Fiscal Year
Fiscal Year EndsApr 27
Most recent quarter
(fully updated)
27-Apr-2001
Most recent quarter
(flash earnings)
31-July-2001
Management Effectiveness
Return on Assets (ttm)16.53%
Return on Equity (ttm)20.58%
Financial Strength
Current Ratio (mrq*)2.76 
Debt/Equity (mrq*)0.03 
Total Cash (mrq)$0 
Short Interest
As of 8-Aug-2001
Shares Short11.3M
Percent of Float0.9%
Shares Short
(Prior Month)
12.2M
Short Ratio3.54 
Daily Volume3.20M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-July-2001, except mrq*/ttm* items as of 27-Apr-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.